ResearcherXi'an Jiaotong UniversityNo recent work listed
Ammar Sarwar
Matched on ORCID iD 0000-0002-8365-4565. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 3
- Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis. Co-author DOI 10.1093/jpp/rgad055↗
- Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities. Co-author DOI 10.1016/j.critrevonc.2022.103858↗
- MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer. Co-author DOI 10.1016/j.bcp.2020.114357↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yanmin Zhang · 3 shared papers, 2021–2023 · strength 0.55
- Paper Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-S… DOI 10.1093/jpp/rgad055↗
- Paper MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer. DOI 10.1016/j.bcp.2020.114357↗
- Paper Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities. DOI 10.1016/j.critrevonc.2022.103858↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.